In conclusion, this study has identified a potential biomarker, CD48, using bioinformatics and machine learning algorithms, which provides a model for detecting atherosclerosis patients who have progressed to heart failure and also suggests potential therapeutic targets. This evidence concerns the gene CD48 and heart failure.